Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
- Type
- Retraction
- Notice date
- 7/14/2023 0:00
- Journal
- The Lancet: Oncology
- Publisher
- Elsevier
- Notice DOI
- 10.1016/s1470-2045(23)00327-3
- Original paper DOI
- 10.1016/s1470-2045(22)00452-1